Skip to main content

EQRx

Closed (deSPAC)

Health Care · biopharmaceutical drug development

What it is
EQRx is a new type of pharmaceutical company committed to developing and delivering innovative medicines to patients at radically lower prices
What it’s doing now
Merging with CM Life Sciences III Inc. (CMLT) — closed (despac).
What you should know
Data is still being assembled for this company — what is shown below is everything we have verified so far.

The business, per its filings

SEC primary

EQRx is a new type of pharmaceutical company committed to developing and delivering innovative medicines to patients at radically lower prices. Launched in January 2020, EQRx is purpose-built, at scale, with a growing catalog of medicines in development in high-cost drug categories and emerging partnerships with leading payers and health systems. Leveraging cutting-edge science and technology and strategic partnerships with stakeholders from across the healthcare system, EQRx aims to provide innovative, patent-protected medicines more efficiently and cost-effectively than ever before. To learn more, visit www.eqrx.com and follow us on social media: Twitter: @EQRxInc, LinkedIn, Instagram: @eqrxinc. EQRx™ and Remaking Medicine™ are trademarks of EQRx. Cautionary Statement Regarding

Source: S-4/A, accession 0001213900-21-062493

What the company says about itself

Web research — not audited
What our web check found

[WEB-INTEL 2026-08-27] 13 finding(s) · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "EQRx, a biotech company aimed at creating less expensive medicine, has raised a massive $200 million Series A" [https://news.crunchbase.com/venture/eqrx-launches-with-200m-series-a-for-cheaper-drugs/] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Privately held EQRx has closed a $500 million funding round, bringing the total it has raised to $750 million." [https://www.barrons.com/articles/start-up-eqrx-which-wants-to-undersell-the-drug-industry-raises-another-500-million-51610364606] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "EQRx has raised approximately $750 million to advance its mission of bringing new medicines to treat life-threatening and chronic diseases" [https://www.goodwinlaw.com/en/news-and-events/news/2021/01/01_11-eqrx-completes-$500-million-series-b] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "EQRx has raised $700.0M across 2 funding rounds. Most recently, it raised $500.0M Series B in January 2021." [https://startupintros.com/orgs/eqrx] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Monday it had raised $500 million more in investment, bringing the total amount it has raised to $750 million." [https://www.statnews.com/2021/01/11/eqrx-raises-money-but-few-details/] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Since launching a year ago, EQRx has raised approximately $750 million" [https://www.businesswire.com/news/home/20210111005320/en/EQRx-Scales-Disruptive-Model-of-Important-New-Medicines-at-Lower-Prices-with-%24500M-Series-B-Financing] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "The financing includes approximately $552 million of cash held in CM Life Sciences III's trust account (assuming no redemptions)" [https://www.baincapital.com/news/eqrx-accelerate-growth-18-billion-raise-through-proposed-combination-cm-life-sciences-iii] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "EQRx to Accelerate Growth with $1.8 Billion Raise through Proposed Combination with CM Life Sciences III" [https://www.baincapital.com/news/eqrx-accelerate-growth-18-billion-raise-through-proposed-combination-cm-life-sciences-iii] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "The deal, announced Friday by EQRx and the special-purpose acquisition company CM Life Sciences II, will give EQRx access to $1.8 billion in" [https://www.biopharmadive.com/news/startup-eqrx-to-take-drug-price-mission-public-through-18b-spac-deal/604590/] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "EQRx to raise $1.8B in SPAC" [https://www.fiercebiotech.com/biotech/eqrx-will-raise-1-8b-through-a-spac-combination-for-lofty-discount-drug-goal] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "EQRx and a life science-focused SPAC, CM Life Sciences III, have signed a definitive business combination agreement worth up to $1.8bn." [https://www.pharmaceutical-technology.com/news/eqrx-merger-deal-cm-life-sciences/] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Revolution Medicines plans to acquire EQRx in an all-stock transaction to gain more than $1 billion in additional capital." [https://www.linkedin.com/posts/revolution-medicines_revolution-medicines-inc-to-acquire-eqrx-activity-7092099648227590144-EiuE] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "the biotech is being bought by Revolution Medicines in an all-stock transaction that secures $1 billion in" [https://www.biospace.com/employer/2214112/eqrx] [WEB-INTEL 2026-08-27] 11 finding(s) · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "The financing includes approximately $552 million of cash held in CM Life Sciences III's trust account (assuming no redemptions)" [https://www.baincapital.com/news/eqrx-accelerate-growth-18-billion-raise-through-proposed-combination-cm-life-sciences-iii] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "EQRx has raised $700.0M across 2 funding rounds" [https://startupintros.com/orgs/eqrx] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "EQRx has raised approximately $750 million to advance its mission" [https://www.goodwinlaw.com/en/news-and-events/news/2021/01/01_11-eqrx-completes-$500-million-series-b] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Privately held EQRx has closed a $500 million funding round, bringing the total it has raised to $750 million" [https://www.barrons.com/articles/start-up-eqrx-which-wants-to-undersell-the-drug-industry-raises-another-500-million-51610364606] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Since launching a year ago, EQRx has raised approximately $750 million" [https://www.businesswire.com/news/home/20210111005320/en/EQRx-Scales-Disruptive-Model-of-Important-New-Medicines-at-Lower-Prices-with-%24500M-Series-B-Financing] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "EQRx has raised $1.97B" [https://pitchbook.com/profiles/company/399420-64] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "The deal, announced Friday by EQRx and the special-purpose acquisition company CM Life Sciences II, will give EQRx access to $1.8 billion in" [https://www.biopharmadive.com/news/startup-eqrx-to-take-drug-price-mission-public-through-18b-spac-deal/604590/] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "EQRx to raise $1.8B in SPAC" [https://www.fiercebiotech.com/biotech/eqrx-will-raise-1-8b-through-a-spac-combination-for-lofty-discount-drug-goal] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "EQRx and a life science-focused SPAC, CM Life Sciences III, have signed a definitive business combination agreement worth up to $1.8bn" [https://www.pharmaceutical-technology.com/news/eqrx-merger-deal-cm-life-sciences/] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "the biotech is being bought by Revolution Medicines in an all-stock transaction that secures $1 billion in" [https://www.biospace.com/employer/2214112/eqrx] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Revolution Medicines plans to acquire EQRx in an all-stock transaction to gain more than $1 billion in additional capital" [https://www.linkedin.com/posts/revolution-medicines_revolution-medicines-inc-to-acquire-eqrx-activity-7092099648227590144-EiuE] [WEB-INTEL 2026-08-28] 11 finding(s) · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "EQRx has raised approximately $750 million" [https://www.businesswire.com/news/home/20210111005320/en/EQRx-Scales-Disruptive-Model-of-Important-New-Medicines-at-Lower-Prices-with-%24500M-Series-B-Financing] · web source asserts a FILING-ONLY figure (deadline / trust [WEB-INTEL 2026-09-08] 9 finding(s) · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "EQRx to raise $1.8B in SPAC deal" [https://www.fiercebiotech.com/biotech/eqrx-will-raise-1-8b-through-a-spac-combination-for-lofty-discount-drug-goal] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "EQRx and CM Life Sciences III have signed a definitive business combination agreement worth up to $1.8bn" [https://www.pharmaceutical-technology.com/news/eqrx-merger-deal-cm-life-sciences/] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "The deal will give EQRx access to $1.8 billion in proceeds" [https://www.biopharmadive.com/news/startup-eqrx-to-take-drug-price-mission-public-through-18b-spac-deal/604590/] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "EQRx made its Nasdaq debut after merging with CM Life Sciences III in a deal that added $1.8 billion to its cash reserves" [https://www.biospace.com/revolution-to-buy-eqrx-in-all-stock-deal-adds-1b-in-cash-to-balance-sheet] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Revolution Medicines plans to acquire EQRx in an all-stock transaction to gain more than $1 billion in additional capital" [https://www.linkedin.com/posts/revolution-medicines_revolution-medicines-inc-to-acquire-eqrx-activity-7092099648227590144-EiuE] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "EQRx has raised approximately $750 million" [https://www.businesswire.com/news/home/20210111005320/en/EQRx-Scales-Disruptive-Model-of-Important-New-Medicines-at-Lower-Prices-with-%24500M-Series-B-Financing] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Privately held EQRx has closed a $500 million funding round, bringing the total it has raised to $750 million" [https://www.barrons.com/articles/start-up-eqrx-which-wants-to-undersell-the-drug-industry-raises-another-500-million-51610364606] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "EQRx has raised $700.0M across 2 funding rounds" [https://startupintros.com/orgs/eqrx] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "EQRx has raised $1.97B" [https://pitchbook.com/profiles/company/399420-64]

Source: company web presence · marketing claims are reported as claims, never merged into the filed figures above.

The deal it’s entering

EQRx is merging with CM Life Sciences III Inc. (CMLT) currently marked Closed (deSPAC).

Headline equity value
PIPE≈ $1.2B · unsourced

Structure per SEC accession(s) 0001193125-23-247498. How to read these numbers: headline vs effective valuation · what a definitive agreement commits

What exactly is being valued, and at what

Common questions

Is EQRx going public?

EQRx has an approved merger with the SPAC CM Life Sciences III Inc. (CMLT). Deal status: Closed (deSPAC).

Does EQRx have revenue?

The filings we've parsed don't state a usable revenue figure yet; this profile is updated as new documents land.

Educational content, not investment advice.

Other health care deals
Same sponsor’s other SPACs
  • SLGC CM Life Sciences II Inc. · Closed (deSPAC)
  • CMLF CM Life Sciences, Inc. · Closed (deSPAC)